Journal of Alzheimers Disease Reports
Scope & Guideline
Bridging Gaps in Alzheimer's Knowledge
Introduction
Aims and Scopes
- Pathophysiology and Mechanisms of Alzheimer's Disease:
Research focusing on the underlying biological processes, including amyloid-beta accumulation, tau pathology, neuroinflammation, and neurodegeneration mechanisms. - Diagnosis and Biomarkers:
Studies exploring various diagnostic tools and biomarkers for early detection of Alzheimer's disease, including neuroimaging, cerebrospinal fluid analysis, and blood-based biomarkers. - Therapeutic Interventions:
Investigations into pharmacological and non-pharmacological treatments aimed at mitigating cognitive decline and improving quality of life for Alzheimer's patients. - Cognitive and Behavioral Health:
Research assessing cognitive functions, behavioral symptoms, and psychological factors in individuals with Alzheimer's disease. - Caregiver Support and Community Health:
Explorations of the impact of Alzheimer's on caregivers, community resources, and interventions designed to support those caring for individuals with dementia. - Social Determinants of Health and Health Disparities:
Studies examining the influence of socioeconomic factors, race, and culture on the prevalence and management of Alzheimer's disease.
Trending and Emerging
- Microbiome and Gut-Brain Axis Research:
An increasing number of studies are exploring the relationship between gut health, microbiota, and Alzheimer's disease, indicating a growing interest in how dietary and microbial factors influence cognitive health. - Digital Health and Technology Use:
The use of digital tools, such as telehealth and mobile health applications, for monitoring and supporting cognitive health is becoming more prevalent, reflecting a trend towards integrating technology in dementia care. - Inflammation and Immune Response:
There is a rising focus on the role of neuroinflammation and the immune system in Alzheimer's disease, with research investigating how inflammatory pathways contribute to disease progression. - Lifestyle Interventions and Prevention Strategies:
Research is increasingly emphasizing non-pharmacological interventions, such as physical activity, diet, and social engagement, aimed at preventing cognitive decline and promoting brain health. - Long COVID and Cognitive Impairment:
Recent publications are examining the effects of COVID-19 on cognitive function, particularly in patients with pre-existing dementia or mild cognitive impairment, highlighting an emerging area of concern in the context of the pandemic.
Declining or Waning
- Traditional Pharmacological Approaches:
While pharmacological studies remain important, there has been a noticeable shift towards exploring innovative therapies, including lifestyle interventions and personalized medicine, leading to a decline in traditional drug trials. - Single-Disease Focus:
Research focusing exclusively on Alzheimer's disease as a standalone condition is decreasing. There is a growing trend towards examining comorbidities and the interplay between Alzheimer's and other neurological or systemic diseases. - Solely Genetic Studies:
The focus on genetic predispositions to Alzheimer's disease is waning as researchers increasingly recognize the multifactorial nature of the disease, incorporating environmental and lifestyle factors into their analyses.
Similar Journals
Frontiers in Aging Neuroscience
Transforming Understanding of Aging and Cognition.Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.
NEUROPSYCHOLOGY
Unraveling the Complexities of Brain-Behavior RelationshipsNEUROPSYCHOLOGY, published by the American Psychological Association, is a leading journal dedicated to advancing the field of neuropsychology and physiological psychology. With an ISSN of 0894-4105 and an E-ISSN of 1931-1559, the journal has established itself as a critical resource for researchers, clinicians, and students interested in the intersection of neuroscience and psychological practice. Recognized as a Q1 journal in its category for 2023, it holds a prominent position within the top quartile of neuropsychology journals, reflecting its rigorous peer-review process and high-quality publications. Covering a wide spectrum of topics from cognitive functions and brain-behavior relationships to clinical assessments and interventions, NEUROPSYCHOLOGY plays a pivotal role in disseminating significant research findings that enhance our understanding of the brain's complexities. Although this journal does not currently offer Open Access, it remains highly regarded for its contribution to the scientific community, as evidenced by its strong Scopus ranking of #34/76 in neuropsychology. As it marks over three decades of publication from 1990 to 2024, NEUROPSYCHOLOGY continues to be an essential publication for those committed to exploring and improving the field.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Pioneering Research for a Brighter Mental Health FutureEuropean Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.
Brain Communications
Advancing Neuroscience Through Open DialogueBrain Communications is an esteemed, open-access academic journal published by Oxford University Press since 2019, focusing on the dynamic field of neuroscience. With a dedicated ISSN and an E-ISSN of 2632-1297, this journal aims to address the intricate relationships between brain functions, psychiatric disorders, and neurobiological mechanisms. The journal stands out in the academic realm, holding a prestigious Q1 ranking across several categories, including Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health for 2023. Notably, it has also secured impressive Scopus ranks in various neuroscience and psychiatry fields, evidencing its commitment to high-quality research. With an impact factor reflective of its growing influence, Brain Communications provides accessible research findings to professionals, researchers, and students alike, fostering a deeper understanding of complex neurological phenomena. This innovative journal is pivotal for anyone involved in advancing knowledge in neuroscience and mental health.
Dementia and Geriatric Cognitive Disorders Extra
Exploring innovative research in geriatric neuroscience.Dementia and Geriatric Cognitive Disorders Extra, published by KARGER in Switzerland, is an esteemed open-access journal dedicated to advancing research in the fields of cognitive neuroscience, geriatrics, and psychiatry. With a commitment to disseminating high-quality research since its inception in 2011, the journal plays a crucial role in highlighting innovative studies that address cognitive disorders associated with aging. As an open-access platform, it ensures that findings are accessible to a global audience, fostering collaboration and knowledge-sharing among researchers, professionals, and students alike. The journal has been recognized for its impact in Cognitive Neuroscience and Psychiatry and Mental Health, achieving a Q3 category ranking, indicating its reputable standing within these fields. By delivering cutting-edge insights and promoting interdisciplinary approaches, Dementia and Geriatric Cognitive Disorders Extra is instrumental in enhancing understanding and treatment of cognitive decline, making it a vital resource for anyone engaged in the study of aging and cognitive health.
Alzheimers & Dementia-Translational Research & Clinical Interventions
Empowering Clinical Practice through Cutting-Edge ResearchAlzheimer's & Dementia: Translational Research & Clinical Interventions, published by WILEY, is a premier open-access journal that has been at the forefront of innovations in the field of neurology and psychiatry since its inception in 2015. With an impressive impact factor reflecting its high-quality research contributions, this journal has been designated as Q1 in both Neurology (Clinical) and Psychiatry and Mental Health categories for 2023, ranking in the top percentiles of their respective Scopus fields. The journal aims to bridge the gap between research and clinical practice, promoting the translation of scientific discoveries into real-world applications for Alzheimer's disease and other dementias. Positioned in the United States, it is a valuable resource for researchers, clinicians, and students dedicated to advancing knowledge and treatment approaches in these critical areas. With its commitment to open access, the journal ensures that vital research is accessible to a broad audience, fostering collaboration and knowledge sharing across the global scientific community.
American Journal of Alzheimers Disease and Other Dementias
Transforming understanding of Alzheimer's disease.The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Empowering healthcare through accessible dementia research.DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.
NEUROPSYCHIATRIE
Transforming Mental Health Through Cutting-Edge ResearchNEUROPSYCHIATRIE, published by SPRINGER WIEN, is a prestigious journal operating from Austria that focuses on advancing the fields of Clinical Psychology and Psychiatry. With an ISSN of 0948-6259 and an E-ISSN of 2194-1327, NEUROPSYCHIATRIE has garnered attention within the academic community, exemplified by its classification in the Q2 category for Clinical Psychology and Q3 for Psychiatry and Mental Health as of 2023. The journal provides a platform for the dissemination of innovative research findings and clinical insights, critical for professionals dedicated to addressing complex neuropsychiatric conditions. Researchers aspiring to explore the intricacies of mental health will find a wealth of knowledge, as evidenced by its Scopus rankings—115th in Clinical Psychology and 260th in Psychiatry and Mental Health—indicating its influential position. Covering a wide range of topics from neurobiology to psychotherapeutic interventions, NEUROPSYCHIATRIE acts as a vital resource, making significant contributions to enhancing clinical practices and fostering interdisciplinary collaborations in mental health.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Leading the charge in neurological and psychiatric innovation.JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.